Entera Bio Ltd (ENTX) — Financial Flexibility Index
Entera Bio Ltd (ENTX) has a Financial Flexibility Index of -1.24x as of September 2025. Free cash flow of $-2.69 Million (operating CF $-2.74 Million minus capex $46.48K) represents -1% of total liabilities ($2.17 Million). Check Entera Bio Ltd (ENTX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Entera Bio Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Entera Bio Ltd across 10 annual periods. See ENTX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Entera Bio Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Entera Bio Ltd. For the full company profile including market capitalisation, see Entera Bio Ltd (ENTX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.20x | $-6.82 Million | $-6.82 Million | $1.31 Million | ▲ +1.6% |
| 2023 | -5.29x | $-7.29 Million | $-7.31 Million | $1.38 Million | ▲ +41.7% |
| 2022 | -9.07x | $-12.45 Million | $-12.50 Million | $1.37 Million | ▼ -243.1% |
| 2021 | -2.64x | $-9.05 Million | $-9.06 Million | $3.42 Million | ▲ +44.3% |
| 2020 | -4.75x | $-10.50 Million | $-10.56 Million | $2.21 Million | ▼ -155.9% |
| 2019 | -1.86x | $-8.88 Million | $-8.92 Million | $4.78 Million | ▲ +38.5% |
| 2018 | -3.02x | $-9.73 Million | $-9.80 Million | $3.23 Million | ▼ -2922.2% |
| 2017 | -0.10x | $-4.47 Million | $-4.53 Million | $44.84 Million | ▼ -1.5% |
| 2016 | -0.10x | $-3.10 Million | $-3.14 Million | $31.53 Million | ▲ +18.7% |
| 2015 | -0.12x | $-3.44 Million | $-3.50 Million | $28.43 Million | — |